The stock of Natural Alternatives International, Inc. (NASDAQ:NAII) is a huge mover today! The stock increased 4.74% or $0.6 on November 22, hitting $13.25. About 122,162 shares traded hands or 100.99% up from the average. Natural Alternatives International, Inc. (NASDAQ:NAII) has risen 5.86% since April 20, 2016 and is uptrending. It has outperformed by 1.30% the S&P500.
The move comes after 6 months positive chart setup for the $91.42M company. It was reported on Nov, 22 by Barchart.com. We have $13.78 PT which if reached, will make NASDAQ:NAII worth $3.66 million more.
According to Zacks Investment Research, “NATURAL ALTERNATIVES INTL INC is engaged in the formulation and production of encapsulated vitamins and nutrients and provides for its clients assistance with foreign registration of products, graphic design, brochures, formulations and a host of other marketing related services.”
Insitutional Activity: The institutional sentiment decreased to 0.89 in Q2 2016. Its down 0.71, from 1.6 in 2016Q1. The ratio turned negative, as 3 funds sold all Natural Alternatives International, Inc. shares owned while 12 reduced positions. 5 funds bought stakes while 19 increased positions. They now own 1.77 million shares or 41.66% less from 3.04 million shares in 2016Q1.
Jpmorgan Chase Company, a New York-based fund reported 4,005 shares. Moreover, Tower Llc (Trc) has 0% invested in Natural Alternatives International, Inc. (NASDAQ:NAII) for 4,204 shares. Vanguard Grp Inc holds 0% or 151,005 shares in its portfolio. Morgan Stanley holds 0% of its portfolio in Natural Alternatives International, Inc. (NASDAQ:NAII) for 1,585 shares. Manufacturers Life Insurance Communications The reported 865 shares or 0% of all its holdings. Geode Cap Limited holds 22,475 shares or 0% of its portfolio. Tci Wealth Advisors accumulated 2,000 shares or 0.01% of the stock. Moreover, Nationwide Fund Advisors has 0% invested in Natural Alternatives International, Inc. (NASDAQ:NAII) for 10,000 shares. Renaissance Techs Lc has 348,900 shares for 0.01% of their US portfolio. Oxford Asset Mgmt last reported 79,298 shares in the company. Ladenburg Thalmann Fin last reported 0% of its portfolio in the stock. Bankshares Of America De holds 216 shares or 0% of its portfolio. Thompson Davis And Com Inc reported 250 shares or 0% of all its holdings. The Texas-based Eagle Global Llc has invested 0.01% in Natural Alternatives International, Inc. (NASDAQ:NAII). Dimensional Fund Advisors Lp accumulated 460,156 shares or 0% of the stock.
Insider Transactions: Since June 3, 2016, the stock had 0 insider buys, and 3 insider sales for $1.05 million net activity. Borg Edward had sold 76,522 shares worth $891,481. 2,000 shares were sold by WELDON LEE G, worth $23,800. Shares for $136,668 were sold by LEDOUX MARK A.
More notable recent Natural Alternatives International, Inc. (NASDAQ:NAII) news were published by: Prnewswire.com which released: “Natural Alternatives International, Inc. Announces Fiscal 2017 Q1 Results” on November 07, 2016, also Prnewswire.com with their article: “Natural Alternatives International, Inc. Promotes President and Chief …” published on October 01, 2015, Prnewswire.com published: “Natural Alternatives International, Inc. Announces Issuance of New U.S. Beta …” on April 15, 2016. More interesting news about Natural Alternatives International, Inc. (NASDAQ:NAII) were released by: Prnewswire.com and their article: “Natural Alternatives International, Inc. Announces Fiscal 2015 Results” published on September 18, 2015 as well as Seekingalpha.com‘s news article titled: “Large Downside Expected Near-Term For Natural Alternatives International, Inc.” with publication date: April 29, 2016.
NAII Company Profile
Natural Alternatives International, Inc., incorporated on October 26, 1989, is a formulator, maker and marketer of nutritional supplements. The Firm operates through three divisions: private-label contract manufacturing, patent and trademark licensing, and branded products. The private-label contract manufacturing segment primarily relates to the provision of private-label contract manufacturing services to companies that market and distribute nutritional supplements and other healthcare products. The patent and trademark licensing segment primarily includes direct raw material sales and royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its CarnosSyn trade name. The branded products segment relates to the marketing and distribution of branded nutritional supplements and consists primarily of the products sold under its Pathway to Healing product line.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.